皮肤鳞状细胞癌中NLRP1炎症小体通路被沉默
本研究分析皮肤鳞状细胞癌(SCC)中炎症小体活化及蛋白表达,发现SCC细胞系和患者活检组织中NLRP1炎症小体组分及促炎细胞因子表达显著下调,且PYCARD、CASP1、IL1B和NLRP1在SCC细胞系中可能因甲基化而沉默,提示该通路下调可能利于皮肤肿瘤晚期发展。
要点
- SCC中NLRP1、ASC、caspase-1及proIL-1β蛋白水平较健康皮肤降低。
- SCC细胞系中PYCARD、CASP1、IL1B和NLRP1表达可能因甲基化沉默。
- 炎症小体通路下调可能促进皮肤肿瘤晚期发展。
核心结论
- 皮肤鳞状细胞癌中NLRP1炎症小体通路表达下调,可能利于肿瘤晚期发展。
研究设计与样本
- 研究分析人原代角质形成细胞和皮肤癌来源SCC细胞系的mRNA与蛋白水平,并比较患者来源SCC活检样本与健康皮肤的蛋白表达。
主要发现
- SCC细胞系中NLRP1炎症小体组分表达强烈下调,促炎细胞因子proIL-1β和proIL-1α表达降低。
- 患者来源SCC活检样本中NLRP1、ASC、caspase-1和proIL-1β蛋白水平较健康皮肤降低。
- SCC细胞系中PYCARD(ASC)、CASP1、IL1B和NLRP1表达可能由甲基化沉默。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The inflammasome protein NLRP1 is an important innate immune sensor in human keratinocytes, and, together with ASC and caspase-1, it mediates the activation and secretion of the proinflammatory cytokines IL-1β and IL-18. These cytokines and inflammasomes can have partly opposing roles during tumorigenesis in mice. In contrast, ASC expression is impaired in different types of cancer in humans. In this study, we analyzed inflammasome activation and expression of inflammasome proteins, including their downstream cytokines, in squamous cell carcinomas, a type of nonmelanoma skin cancer derived from keratinocytes. We assessed mRNA and protein levels in human primary keratinocytes and skin carcinoma-derived SCC cell lines and detected a strong down-regulation of expression of NLRP1 inflammasome components, as well as reduced expression of the proinflammatory cytokines proIL-1β and proIL-1α. Protein levels of NLRP1, ASC, caspase-1, and proIL-1β were reduced in patient-derived SCC biopsy samples compared with healthy skin. Furthermore, the results suggest that expression of PYCARD (ASC), CASP1, IL1B, and NLRP1 is silenced by methylation in SCC cell lines. In conclusion, the down-regulation of the inflammasome pathway in SCCs might favor late tumor development in human skin.
引用
- Sand J, Fenini G, Grossi S, et al. The NLRP1 Inflammasome Pathway Is Silenced in Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2019. PMID: 30738816. doi:10.1016/j.jid.2019.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。